Content newly created and adapted for this training suite.
On December 30, 2022, the DATA X-Waiver requirement to prescribe medication for opioid use disorder (MOUD) was eliminated by the federal government under the Mainstreaming Addiction Treatment (MAT) Act, section 1262 of the Consolidated Appropriations Act of 2023.
While the DATA X-Waiver has been eliminated, there is an additional requirement that controlled medication prescribers must receive at least 8 hours of education on treating and managing patients with substance use disorder. This is a one-time training requirement which will be self-reported on the DEA registration form for new and renewing applicants starting June 27, 2023. This interactive training suite has been developed in accordance with the recommendations from the DEA and SAMHSA for the Medication Access and Training Expansion (MATE) Act.
SAMHSA recommends that educational content includes education on the prevention, recognition, and care of people with substance use disorders, including those with concurrent pain and/or psychiatric or medical co-morbidities. The recommended curricular elements include: substance use disorders, effective treatment planning, and pain management and substance misuse.
Most programs have also been designed to satisfy, in part, the North Carolina Medical Board's CME requirement for controlled substance prescribers. Per NCAC rules: As of July 1, 2017, all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirements as set forth by their licensing boards. Requirements vary by discipline and board.
While only eight modules are necessary to fulfill the requirement, this training offers sixteen options. We hope that learners will be able to choose the topics that they believe will benefit their work most. Four modules are highlighted as “recommended” because MAHEC providers believe they provide key information for the effective treatment of substance use disorders, and should be used as the foundation of this training. The following modules are recommended:
Register below for each module in this training suite.
This requirement applies to physicians, physician assistants, nurse practitioners, podiatrists, dentists, and other practitioners that prescribe controlled substances who are applying for or renewing their DEA license after June 27, 2023.